These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20695051)

  • 1. Cardiovascular disease risk profile tools and New Zealand--absolutely the best way forward.
    Wells S; Riddell T; Jackson R
    J Prim Health Care; 2010 Jun; 2(2):168-9. PubMed ID: 20695051
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular disease risk profile tools and new zealand--the best way forward?
    Boland P; Moriarty H
    J Prim Health Care; 2009 Dec; 1(4):328-31. PubMed ID: 20690346
    [No Abstract]   [Full Text] [Related]  

  • 3. Trading PREDICTions.
    Cox B
    N Z Med J; 2007 Sep; 120(1261):U2707. PubMed ID: 17853929
    [No Abstract]   [Full Text] [Related]  

  • 4. Integrated electronic decision support increases cardiovascular disease risk assessment four fold in routine primary care practice.
    Wells S; Furness S; Rafter N; Horn E; Whittaker R; Stewart A; Moodabe K; Roseman P; Selak V; Bramley D; Jackson R
    Eur J Cardiovasc Prev Rehabil; 2008 Apr; 15(2):173-8. PubMed ID: 18391644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing Māori/non-Māori differences in cardiovascular disease risk and risk management in routine primary care practice using web-based clinical decision support: (PREDICT CVD-2).
    Riddell T; Jackson RT; Wells S; Broad J; Bannink L
    N Z Med J; 2007 Mar; 120(1250):U2445. PubMed ID: 17339901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving Māori health outcomes with decision support.
    Hider P
    N Z Med J; 2007 Mar; 120(1250):U2443. PubMed ID: 17339899
    [No Abstract]   [Full Text] [Related]  

  • 7. Noninvasive assessment of cardiovascular risk: from Framingham to the future.
    Vogel RA; Benitez RM
    Rev Cardiovasc Med; 2000; 1(1):34-42. PubMed ID: 12457150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute Predict: a clinician-led cardiovascular disease quality improvement project (Predict-CVD 12).
    Kerr AJ; Looi JL; Garofalo D; Wells S; McLachlan A
    Heart Lung Circ; 2010; 19(5-6):378-83. PubMed ID: 20392667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of New Zealand CVD risk chart adjustments for family history and ethnicity on eligibility for treatment (PREDICT CVD-5).
    Wells S; Kerr A; Broad J; Riddell T; Kenealy T; Jackson R
    N Z Med J; 2007 Sep; 120(1261):U2712. PubMed ID: 17853933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Web-based assessment of cardiovascular disease risk in routine primary care practice in New Zealand: the first 18,000 patients (PREDICT CVD-1).
    Bannink L; Wells S; Broad J; Riddell T; Jackson R
    N Z Med J; 2006 Nov; 119(1245):U2313. PubMed ID: 17146488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sophisticated decision-support tools stay one step ahead of CVD.
    Dis Manag Advis; 2002 Aug; 8(8):121-5, 113. PubMed ID: 12233141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gaps in primary care documentation of cardiovascular risk factors.
    Rafter N; Wells S; Stewart A; Selak V; Whittaker R; Bramley D; Roseman P; Furness S; Jackson RT
    N Z Med J; 2008 Feb; 121(1269):24-33. PubMed ID: 18278079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-cost strategies to predict cardiovascular disease.
    Wilson PW; Narayan KM
    Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):518-9. PubMed ID: 18628774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular disease risk factor assessment and management in gout: an analysis using guideline-based electronic clinical decision support.
    Colvine K; Kerr AJ; McLachlan A; Gow P; Kumar S; Ly J; Wiltshire C; Robinson E; Dalbeth N
    N Z Med J; 2008 Nov; 121(1285):73-81. PubMed ID: 19079439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formalization of clinical practice guidelines.
    Buchtela D; Peleska J; Veselý A; Zvárová J; Zvolský M
    Stud Health Technol Inform; 2008; 136():151-6. PubMed ID: 18487723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Old and new scoring systems for assessing cardiovascular risks: problems with the validity, the precision and the homogenicity of the risk categories].
    Smulders YM; Spijkerman AM; Kostense PJ; Bouter LM; Stehouwer CD
    Ned Tijdschr Geneeskd; 2004 Dec; 148(50):2480-4. PubMed ID: 15638194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Riskard 2005. New tools for prediction of cardiovascular disease risk derived from Italian population studies.
    Menotti A; Lanti M; Agabiti-Rosei E; Carratelli L; Cavera G; Dormi A; Gaddi A; Mancini M; Motolese M; Muiesan ML; Muntoni S; Muntoni S; Notarbartolo A; Prati P; Remiddi S; Zanchetti A
    Nutr Metab Cardiovasc Dis; 2005 Dec; 15(6):426-40. PubMed ID: 16314229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk evaluation in action for cardiovascular health.
    Gilski DJ; Borkenhagen B
    Crit Care Nurse; 2005 Feb; 25(1):26-8, 30-7. PubMed ID: 15756731
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cardiovascular risk assessment for informed decision making. Validity of prediction tools].
    Lenz M; Mühlhauser I
    Med Klin (Munich); 2004 Nov; 99(11):651-61. PubMed ID: 15583875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein in cardiovascular risk prediction. Zooming in and zooming out.
    Maseri A
    Ital Heart J; 2001 Mar; 2(3):155-6. PubMed ID: 11305525
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.